These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9307761)

  • 1. The prevalence of hereditary haemochromatosis in a diabetic population.
    Turnbull AJ; Mitchison HC; Peaston RT; Lai LC; Bennett MK; Taylor R; Bassendine MF
    QJM; 1997 Apr; 90(4):271-5. PubMed ID: 9307761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing manifestations of hereditary haemochromatosis through population based screening.
    Haddow JE; Ledue TB
    J Med Screen; 1994 Jan; 1(1):16-21. PubMed ID: 8790482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of genetic haemochromatosis among diabetic patients.
    Phelps G; Chapman I; Hall P; Braund W; Mackinnon M
    Lancet; 1989 Jul; 2(8657):233-4. PubMed ID: 2569052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for haemochromatosis in the diabetic clinic.
    George DK; Evans RM; Crofton RW; Gunn IR
    Ann Clin Biochem; 1995 Nov; 32 ( Pt 6)():521-6. PubMed ID: 8579282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for genetic haemochromatosis in a rheumatology clinic.
    Olynyk J; Hall P; Ahern M; Kwiatek R; Mackinnon M
    Aust N Z J Med; 1994 Feb; 24(1):22-5. PubMed ID: 8002853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
    Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T
    Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Importance of hereditary haemochromatosis in the care of diabetes mellitus].
    Wittmann I; Wagner L; Markó L; Tamaskó M; Laczy B; Márton M; Cseh J; Melegh B
    Orv Hetil; 2007 Jan; 148(3):111-5. PubMed ID: 17289614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of establishing appropriate local reference values for the screening of hemochromatosis: a study of three different control populations and 136 hemochromatosis family members. Hemochromatosis Clinical and Research Group.
    Porto G; Vicente C; Fraga J; da Silva BM; de Sousa M
    J Lab Clin Med; 1992 Mar; 119(3):295-305. PubMed ID: 1541878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: targeted screening for hereditary haemochromatosis in high-risk groups.
    DuBois S; Kowdley KV
    Aliment Pharmacol Ther; 2004 Jul; 20(1):1-14. PubMed ID: 15225165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of subjects with abnormal iron studies: role of the hepatic iron index.
    Chapman BA; Horton DM; Burt MJ; Romeril KR; Walmsley TA; Grant SJ; George P
    N Z Med J; 1994 Dec; 107(991):504-7. PubMed ID: 7830980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis.
    Wood MJ; Crawford DHG; Wockner LF; Powell LW; Ramm GA
    Liver Int; 2017 Sep; 37(9):1382-1388. PubMed ID: 28231420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study.
    Ellervik C; Mandrup-Poulsen T; Nordestgaard BG; Larsen LE; Appleyard M; Frandsen M; Petersen P; Schlichting P; Saermark T; Tybjaerg-Hansen A; Birgens H
    Lancet; 2001 Oct; 358(9291):1405-9. PubMed ID: 11705485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary hemochromatosis and its elusive natural history.
    McDonnell SM; Parrish RG
    Arch Intern Med; 2003 Nov; 163(20):2421-3; author reply 2427. PubMed ID: 14609775
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for hereditary haemochromatosis within families and beyond.
    McCune CA; Ravine D; Worwood M; Jackson HA; Evans HM; Hutton D
    Lancet; 2003 Dec; 362(9399):1897-8. PubMed ID: 14667749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of primary hemochromatosis].
    Swinkels DW; Marx JJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older.
    Baer DM; Simons JL; Staples RL; Rumore GJ; Morton CJ
    Am J Med; 1995 May; 98(5):464-8. PubMed ID: 7733125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary hemochromatosis: presentation and diagnosis in the 1990s.
    Bacon BR; Sadiq SA
    Am J Gastroenterol; 1997 May; 92(5):784-9. PubMed ID: 9149185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary hyperferritinaemia-cataract syndrome and differential diagnosis of hereditary haemochromatosis.
    Sanders SJ; Suri M; Ross I
    Postgrad Med J; 2003 Oct; 79(936):600-1. PubMed ID: 14612607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic haemochromatosis.
    Rosalki SB
    Int J Clin Pract; 2002 Oct; 56(8):609-10. PubMed ID: 12425371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population.
    Aleman S; Endalib S; Stål P; Lööf L; Lindgren S; Sandberg-Gertzén H; Almer S; Olsson S; Danielsson A; Wallerstedt S; Hultcrantz R
    Scand J Gastroenterol; 2011 Sep; 46(9):1118-26. PubMed ID: 21675821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.